Tags : Krintafel

GSK’s Krintafel (tafenoquine) Receives FDA Approval Preventing the Relapse of

Shots: The approval is based on Detective Part 1 & Part 2 (TAF112582) and Gather (TAF116564) studies results assessing Krintafel (tafenoquine, 300mg) in 800 patients with relapse P.vivax malaria The study demonstrated with safety & effective results in global clinical development P.vivax relapse program built in collaboration with Medicines for Malaria Venture(MMV) Krintafel (tafenoquine, 300mg) […]Read More